Title |
Authors |
Regulatory Issues |
IPAC-RS Strategic Vision |
David Cipolla, Terrence Tougas, Mary Devlin Capizzi, Don Chambers, Dave Parkins, Andy Rignall, Jackie Schumacher, Mary Ann Smith |
A “Compare and Contrast” of International Guidelines Impacting the Pharmaceutical and Clinical Development of New and Subsequent Market Entry OINDPs. Part A: Clinical and Part B: CMC |
J. Schumacher, R. Ormiston, R. Alekel, B. Berner, N. Bowles, M. James, J.R. Keegstra, S. Lyapustina, A. Rignall, C. Rogerson, B. Thompson |
Establishing the Shelf Life of Pharmaceutical Products |
Terrence Tougas, Suntara Cahya, David Christopher, Dennis Sandell |
The IPAC-RS Supplier GMP Guideline: A Platform for New Directions in Supplier Quality Control |
Barbara Falco, Paul Beasley, Thomas Gaspar, John Goulding, Thomas Haselwander, Louis Leger, Christian, Meusinger, Lee Nagao, Tanya Naidu, Linda Nield, Ray Oksala, Philippe Pitard, Suzette Roan, Andrew Saunders, Jo Ward, Andrew Wood
|
Points to Consider for a Pharmaceutical Development "P2" Report for OINDP: An Industry View |
Jackie Schumacher, Alex Bell, Mark Broughton, Mukul Dalvi, John Hart, Susan Holmes, Terry Kosobud, Paul Lucas, Lee Nagao, Tilo Schönbrodt, Mary Ann Smith, Terrence Tougas, Tony Wilkinson, Xian-Ming Zeng |
Rationalized Approach to Chemistry, Manufacturing & Control (CMC) Requirements for Orally Inhaled and Nasal Drug Products (OINDPs) Based on Risk Management
Risk Managment Interactive Poster |
Stephen Horhota, Robert Berger, Noel Butterworth, Barbara Davidson, Andrew Grant, Eric Johansson, Sebastian Kaerger, Stefan Leiner, Svetlana Lyapustina, Rajni Patel, Ann Purrington |
USP Aerosols Experts Committee: Responsibilities and Activities |
Anthony Hickey and Kahkashan Zaidi |
Aerodynamic Particle sizing |
Comparative Analysis of Manual Versus Automated Actuation Parameters for Droplet Size Determination by Laser Diffraction for Spray Devices |
Robin Spivey and LaMonica Ware |
A Comparison of Different Approaches to Estimating the Mass Median Aerodynamic Diameter (MMAD) of OINDP Aerosols from Cascade Impactor Data |
Terrence Tougas, David Christopher, Monisha Dey, Jolyon Mitchell, Svetlana Lyapustina, Michael Van Oort, Stephen Stein |
Controlling Variability during Aerodynamic Particle Size Measurement |
Sarah Walker, Debbie Kraus, Tamsin Jenkins, Liz Clift |
Lean Data Analysis for Cascade Impaction Measurements |
Terrence Tougas, Dave Christopher, Svetlana Lyapustina, Jolyon Mitchell, Helen Strickland, Bruce Wyka |
Utilization of a climate box for optimization of cascade impaction measurements ensuring control of impactor temperature |
Ellen Bitterle, Anke Luithlen, Karin Reul, Albert Bucholski, Manfred Keller |
Analytical Methods – General |
Analytical Methods Quality by Design (AM-QbD) Risk Assessments undertaken within GlaxoSmithKline (World Wide Inhaled Product Development) for Orally Inhaled and Nasal Drug Products |
Andrew J. Crumpton, Geoffrey E. Daniels, Karl M. Ennis, and Nick C. Turner |
The Discrimination of Robustness and Ruggedness Factors During the Evaluation of Analytical Methods for Orally Inhaled and Nasal Drug Products. |
Andy Rignall, David Christopher, Andrew Crumpton, Kevin Hawkins, Sebastian Kaerger, Svetlana Lyapustina, Holger Memmesheimer, Adrian Parkinson, Mary Ann Smith |
Quality by Design for Analytical Methods Intended for Use with Orally Inhaled and Nasal Drug Products |
Andy Rignall, David Christopher, Andrew Crumpton, Karl Ennis, Kevin Hawkins, Sebastian Kaerger, Svetlana Lyapustina, Holger Memmesheimer, Adrian Parkinson, Mary Ann Smith |
Quality by Design Systematic Chromatographic Method Development |
Oscar Liu, Justin Pennington, Tina Masiuk, Zhenyu Wang, Honggen Zhang, Kevin DeBoyace, Pallavi Mehta, Brent Donovan |
E&L |
The Extractables and Leachables Safety Information Exchange (ELSIE): Developing an Extractables/Leachables Database |
Douglas Ball, Steve Beck, Arthur Shaw |
How Low can we Go? Sensitivity and the Analytical Evaluation Threshold for Leachables |
James Mullis, Scott Pennino, Daniel Norwood |
Investigating Paradigms for Extractables and Leachables Management in Orally Inhaled and Nasal Drug Products |
Daniel L. Norwood, Cheryl L.M. Stults, Tim Chesworth, David Christopher, Antonio Medina, Lee Nagao, Ann Purrington, Arthur Shaw, Caesar Snodgrass-Pilla, Terrence Tougas, Benoit Walter |
Tackling the Extractables and Leachables Challenge: Managing Extractables Along the Supply Chain |
Cheryl Stults, Barbara Falco, Matthew Coates, Jason Creasey, Daniel Dohmeier, Andrew Feilden, Simon Kaar, James Mullis, Lee Nagao, Daniel Norwood, Gaby Reckzuegel, Bobbijo Redler, Andy Rignall, Caesar Snodgrass-Pilla, Xian-Ming Zeng |
Use of Designed Experiments to Understand and Control Variability of Extractables |
Nathan Knotts, William Duffield, Arthur J. Shaw, Suzette Roan, Cheryl L.M. Stults |
Formulation & Process development |
Development of Robust Capsule based Dry Powder Inhalation Formulations: Moving towards Quality by Design |
Angela Armanni, Ruth Leu Marseiler, Mukul Dalvi, Markus Otz, Jean-Daniel Bonny |
From Understanding to Control: A Successful Application of Multivariate Modeling in Commercial Manufacturing |
Beth Morgan, Chris Wong, Wilvan Wee, Brad Flynn, Mike Bowley |
Predicting bronchodilator response of a short acting beta-2-agonist from aerodynamic particle size data using artificial neural networks |
M. de Matas, Q. Shao, M. Biddiscombe, H. Chrystyn, P.J. Barnes, O.S. Usmani |
Particulate characterization |
Detecting Siliceous Flakes in Glass Containers using Microscopic Techniques |
Frank Bales, Brian Mitchell |
Foreign Particles Method Development and Identification in Inhalable Drug Products with Single Particle Explorer in the QbD Paradigm |
Oliver K. Valet, Markus Lankers |
Simultaneous Raman micro-spectroscopy and Morphological analysis of Particles from an Orally Inhaled Product – A Novel Analytical Approach for QbD |
E. Neil Lewis, Kenneth S. Haber, Linda H. Kidder, Janie Dubois |